[82] demonstrated that low TET2 mRNA expression was an independent prognostic factor in patients with breast carcinoma (HR [95% CI] = 1.47 [1.11–1.92], p = 0.0054) (Table 3). This evidence concerns the gene TET2 and breast carcinoma.